Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in Neonatal Intensive Care: a Pragmatic, Multicentre, Parallel Cluster Randomised Hybrid Implementation-effectiveness Study.

NCT05993442 is registered in ClinicalTrials.gov with PENTA Foundation as lead sponsor.

NCT NCT05993442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05993442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in Neonatal Intensive Care: a Pragmatic, Multicentre, Parallel Cluster Randomised Hybrid Implementation-effectiveness Study.
Lead sponsor
PENTA Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2024
Completion date
May 31, 2026
Enrollment
3,080 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

infection prevention, infection, bacterial